Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2*

Angiopoietin-1 (Ang1) is an essential molecule for blood vessel formation; however, little is known about the structure-function relationships of Ang1 with its receptor, Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain-2′). In this study, we generated several Ang1 and angiopoietin-2 (Ang2) variants to define the role of the superclustering and oligomerization domains of the Ang1 protein. Then we analyzed the molecular structure of the variants with SDS-PAGE and rotary metal-shadowing transmission electron microscopy (RMSTEM) and determined the effects of these variants on the binding and activation of Tie2. Ang1 exists as heterogeneous multimers with basic trimeric, tetrameric, and pentameric oligomers, whereas Ang2 exists as trimeric, tetrameric, and pentameric oligomers. The variant Ang1C265S, consisting of trimers, tetramers, and pentamers without multimeric forms of Ang1, yielded less Tie2 activation than did Ang1, whereas monomeric Ang1 (Ang1/FD), dimeric Ang1 variants (Ang1D2, and Ang1D3), and dimeric and trimeric Ang1 variant (Ang1D1) dramatically lost their ability to bind and activate Tie2. An Ang1 protein in which two cysteines (amino acids 41 and 54) were replaced with serines (Ang1C41S/C54S) formed mostly dimers and trimers that were not able to bind and activate Tie2. In addition, improper creation of a new cysteine in Ang2 (Ang2S263C) dramatically induced Ang2 aggregation without activating Tie2. In conclusion, proper oligomerization of Ang1 having at least four subunits by the intermolecular disulfide linkage involving cysteines 41 and 54 is critical for Tie2 binding and activation. Thus, our data shed a light on the structure-function relationships of Ang1 with Tie2.

[1]  Guoqing Yang,et al.  Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4 Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.M400138-JLR200 , 2004, Journal of Lipid Research.

[2]  D. Dumont,et al.  Functional inhibition of secreted angiopoietin: a novel role for angiopoietin 1 in coronary vessel patterning. , 2004, Biochemical and biophysical research communications.

[3]  Ju-Hyun Kim,et al.  Biological characterization of angiopoietin‐3 and angiopoietin‐4 , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  H. Augustin,et al.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004, Blood.

[5]  Sung Hyun Kim,et al.  COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Terasaki,et al.  A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro , 2004, Journal of neurochemistry.

[7]  Lois E. H. Smith,et al.  Adipose tissue growth and regression are regulated by angiopoietin-1. , 2003, Biochemical and biophysical research communications.

[8]  S. Ryu,et al.  Localization of Tie2 and phospholipase D in endothelial caveolae is involved in angiopoietin-1-induced MEK/ERK phosphorylation and migration in endothelial cells. , 2003, Biochemical and biophysical research communications.

[9]  K. Alitalo,et al.  Gene transfer as a tool to induce therapeutic vascular growth , 2003, Nature Medicine.

[10]  Robert G. Parton,et al.  Caveolae — from ultrastructure to molecular mechanisms , 2003, Nature Reviews Molecular Cell Biology.

[11]  G. Koh,et al.  Angiopoietin-1 Reduces VEGF-Stimulated Leukocyte Adhesion to Endothelial Cells by Reducing ICAM-1, VCAM-1, and E-Selectin Expression , 2001, Circulation research.

[12]  K. Alitalo,et al.  Tie receptors: new modulators of angiogenic and lymphangiogenic responses , 2001, Nature Reviews Molecular Cell Biology.

[13]  Y. Pak,et al.  The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis. , 2001, Cardiovascular research.

[14]  K. Alitalo,et al.  Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. , 2001, Cardiovascular research.

[15]  J. Chae,et al.  Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral Vascularization , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[17]  T. Noda,et al.  A Role for Hematopoietic Stem Cells in Promoting Angiogenesis , 2000, Cell.

[18]  G. Koh,et al.  Characterization and Expression of a Novel Alternatively Spliced Human Angiopoietin-2* , 2000, The Journal of Biological Chemistry.

[19]  G. Koh,et al.  Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. , 2000, Circulation.

[20]  N. Glazer,et al.  Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.

[21]  P. Carmeliet Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[22]  J. Kim,et al.  Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. , 2000, Circulation research.

[23]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[24]  William Lee,et al.  Angiopoietin-1 and -2 Coiled Coil Domains Mediate Distinct Homo-oligomerization Patterns, but Fibrinogen-like Domains Mediate Ligand Activity* , 1999, The Journal of Biological Chemistry.

[25]  N. Copeland,et al.  Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Thomas N. Sato,et al.  Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.

[27]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[28]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[29]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[30]  Thomas N. Sato,et al.  Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  U. Aebi,et al.  Preparation of single molecules and supramolecular complexes for high-resolution metal shadowing. , 1983, Journal of ultrastructure research.

[32]  김경태,et al.  Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2 = Angiopoietin-1의 Tie2 수용체에 대한 결합과 인산화를 위해 요구되는 Angiopoietin-1의 다중화에 대한 연구 , 2006 .

[33]  G. Yancopoulos,et al.  Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering , 2003, Nature Structural Biology.